Chronic Rhinosinusitis (CRS): Clinical Trials

3 trials for Chronic Rhinosinusitis (CRS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Chronic Rhinosinusitis (CRS): new trials by email Literature Review of Chronic Rhinosinusitis (CRS) trials Research Report on Chronic Rhinosinusitis (CRS)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra-Sinus Povidone-Iodine and Budesonide After Endoscopic Sinus Surgery for Chronic Rhinosinusitis
Povidone-Iodine and Budesonide Gel-Forming Suspension, Placebo Gel-Forming Suspension - Chronic Rhinosinusitis (CRS)
Phase 3Not yet recruitingAmin Javer1802026-03-302026-02-03
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID, CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID - Cystic Fibrosis (CF), Chronic Rhinosinusitis (CRS)
Phase 3RecruitingIndiana University642025-07-022025-12-16
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
Dupilumab - Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS)
Phase 3WithdrawnNational Institute on Deafness and Other Communication Disorders (NIDCD)2024-07-172024-07-25

Narrower conditions

Allergic Fungal Sinusitis (1)  ·  Asthma (1)  ·  Cystic Fibrosis (1)  ·  Nasal Polyps (1)

Broader conditions

Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Bacterial Infections and Mycoses (1)  ·  Bronchial Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Infant, Newborn, Diseases (1)  ·  Infections (1)  ·  Lung Diseases, Obstructive (1)  ·  Mycoses (1)  ·  Nose Diseases (1)

Interventions

Povidone-Iodine (1)  ·  Steroids (1)  ·  dupilumab (1)

Sponsors

Amin Javer (1)  ·  Indiana University (1)  ·  National Institute on Deafness and Other Communication Disorders (NIDCD) (1)

Countries

United States (1)

Top investigators

Elisa Illing, MD (1)  ·  Joshua Levy, M.D. (1)